Diageo Surprises with Modest Sales Growth, but US Weakness and Debt Loom

What happened

Diageo's quarterly organic net sales grew 0.3% year-over-year, surprising analysts as strength in Europe and Latin America offset continued weakness in its largest market, the United States. This contrasts with the challenging FY25, where reported net sales were flat and operating profit fell 27.8% due to exceptional charges and margin compression. While the growth is a positive sign, Diageo still faces elevated leverage (3.5x net debt/EBITDA), leadership transitions, and execution risks from its Accelerate transformation program. The stock, down ~32% over the past year, trades about 35% above a conservative DCF estimate of ~$66 per share, suggesting limited margin of safety. The results offer a glimmer of hope for stabilization, but the fundamental headwinds of category maturation, debt, and program execution remain.

Implication

For investors, the quarter shows Diageo's geographic diversification is working, with Europe and Latin America compensating for US softness. However, sustained organic growth and margin improvement are needed to justify the current valuation, which exceeds conservative DCF estimates. Elevated leverage and leadership uncertainty add risk, so any significant position should wait for clearer deleveraging and consistent regional performance. Success of the Accelerate plan is critical; without it, the stock could continue to de-rate. Given these mixed signals, maintaining a wait-and-see approach is prudent, with potential to upgrade if US trends improve and FCF targets become achievable.

Thesis delta

The slight quarterly growth reduces near-term downside risk but does not alter the core thesis of a high-quality franchise under pressure. The WAIT judgment remains appropriate, as one quarter of 0.3% growth is insufficient to confirm a turnaround.